Dermata Therapeutics, Inc.
DRMA
$1.21
-$0.02-1.63%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -31.91% | -28.54% | 137.92% | -24.08% | 31.00% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 37.40% | 16.14% | 80.98% | -23.54% | 4.41% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 4,716.25% | 4,790.00% | 159.52% | -70.00% | -94.46% |
| Total Current Assets | -22.35% | -25.38% | 122.52% | -24.16% | 26.81% |
|
|
|||||
| Total Current Assets | -22.35% | -25.38% | 122.52% | -24.16% | 26.81% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -19.87% | -25.38% | 122.52% | -24.16% | 26.81% |
|
|
|||||
| Total Accounts Payable | 170.66% | -77.19% | -42.97% | -47.50% | -68.83% |
| Total Accrued Expenses | 16.45% | -43.88% | 1.27% | -39.22% | 3.62% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 78.61% | -61.07% | -16.85% | -42.90% | -46.50% |
|
|
|||||
| Total Current Liabilities | 78.61% | -61.07% | -16.85% | -42.90% | -46.50% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 78.61% | -61.07% | -16.85% | -42.90% | -46.50% |
|
|
|||||
| Common Stock & APIC | 8.29% | 8.26% | 18.18% | 11.99% | 20.15% |
| Retained Earnings | -12.01% | -10.45% | -11.51% | -14.15% | -17.40% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -37.88% | -12.17% | 298.65% | -16.47% | 69.20% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -37.88% | -12.17% | 298.65% | -16.47% | 69.20% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -37.88% | -12.17% | 298.65% | -16.47% | 69.20% |
|
|
|||||